Brought to you by 3Bar Biologics, hear from the experts why the delivery of Ag Biologicals is important to building farmer’s trust, and what we can do to improve compatibility with different inputs and equipment. Panelists include Moderator, Jane Fife, CTO at 3Bar Biologics • Jim Lappin, Director of SIMPAS Product Portfolio and Alliances at AMVAC • David Flack, Vice President, Business Development at New Leaf Symbiotics • Adam Kayser, Technical Agronomist for the Central and Southern US at Novozymes • Dan Poston, Director of Agronomy at Pivot Bio.

Learn about impactful innovations as well as new startup companies generated from Abigail Wexner Research Institute at Nationwide Children’s Hospital. Join us for talks highlighting novel interventions from Nationwide Children’s researchers.

Join us in-person or via livestream for a conversation about the tremendous growth in the Cell and Gene Therapy field. Please make reservations by Tuesday, March 15th. We cannot accommodate walk-ins. The event is presented by Columbus Metropolitan Club, hosted by Eddie Pauline, BioOhio President & CEO, and features • Timothy J. Miller, Ph.D.,CEO, President and Co-Founder, Forge Biologics • BioOhio Board Member Eli Phillips Jr., PharmD, Vice President for Specialty Solutions, Cardinal Health • Samantha M. Jaglowski, M.D., Associate Professor of Hematology, Medical Director of the Blood and Marrow Transplant Program, and member of the Leukemia Research Program, The James Comprehensive Cancer Center at The Ohio State University.

Join us on July 28 for the inaugural Ohio HealthTech Summit brought to you by OhioX and University Hospitals Ventures. This virtual event will take a deep look at the latest technology trends and activities happening in Ohio’s rich healthcare innovation ecosystem. Topics range from digital and virtual health to emerging technologies like extended reality, AI, and blockchain. Learn how Ohio providers, corporations, entrepreneurs, and investors are partnering to deliver outstanding care to Ohio consumers and communities.

AFDO / RAPS Healthcare Products Collaborative presents the AI Summit, an artificial intelligence summit where world healthcare leaders come together. Join us for a behind-the-scenes look into how Artificial Intelligence (AI) is being used in pharma, biopharma, and medical devices! This year’s summit will be held in person at Sonesto Columbus Downtown in Columbus, Ohio.

The Association of Food and Drug Officials (AFDO) and the Regulatory Affairs Professionals Society (RAPS) have come together to support sharing, collaboration, and learning across the global healthcare products community. With a focus on fostering open discussions of the most pressing issues facing the industry, the AFDO/RAPS Healthcare Products Collaborative will carry on Xavier Heath’s legacy of delivering the Combination Products Summit. The AFDO/RAPS Healthcare Products Collaborative combination products community continues to be led by top FDA officials and worldwide industry leaders who built the framework for the regulatory landscape of combination products. This global community drives innovation and navigates the complexities specific to the world of combination products, resulting in the delivery of safe, effective, and high-quality products to the patients who need them.

The Advancing Healthcare Innovation Summit (AHIS2022) is a major healthcare conference and exhibit showcasing the latest innovations related to healthcare and medical sciences. AHIS2022 is a networking conference for all stakeholders in healthcare innovations.

The Association of Food and Drug Officials (AFDO) and the Regulatory Affairs Professionals Society (RAPS) have come together to support sharing, collaboration, and learning across the global healthcare products community. With a focus on fostering open discussions of the most pressing issues facing the industry, the AFDO/RAPS Healthcare Products Collaborative will carry on Xavier Heath’s legacy of delivering Pharmalink in 2022. At PharmaLink, we work to find solutions that will increase confidence in product quality throughout your products’ life cycle management and global supply chain. We do this by aligning with the strategic priorities of the FDA and industry – and by helping participants create network links to drive compliant innovations. The solutions might not be evident within our companies, or our industry, so we explore beyond our industry – beyond borders and beyond comfort zones.

Presented By: Ross Youngs – Founder/CEO of Biosortia Microbiomics. Both online and in-person sessions will be offered for this event. For over 70 years, the quest to obtain the metabolites or small molecules in unculturable microbes has been a goal of many researchers seeking the best starting points in drug and life science discovery. With only 1% of microbes growing in a culture or bioreactor, the ability to directly obtain has been stymied by nature. The pivot to indirect methods has hit the firewall of nature’s complexity leading mostly to irrelevant and incomplete results. Learn how industrial-scale microbiome mining will open up direct access to these sought-after small molecules from potentially 100% and how this new source will impact therapeutics, agriculture, sustainability, cosmetics, and the entire range of life science discoveries.

Join The Office of Technology Commercialization at Nationwide Children’s Hospital for presentations about new and impactful technologies emerging through research and innovation at Nationwide Children’s Hospital, an update by our licensee Sarepta Therapeutics, and a keynote presentation on the role of the U.S. Food and Drug Administration in accelerating gene and cell therapy innovation to benefit patients. In-person seating is limited.